U.S. Markets closed

Recro Pharma, Inc. (REPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.0400+0.0400 (+2.00%)
At close: 4:00PM EDT
2.0400 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.0000
Open2.0200
Bid2.0200 x 800
Ask2.1800 x 2200
Day's Range1.9800 - 2.0400
52 Week Range1.4900 - 5.2900
Volume372,535
Avg. Volume447,968
Market Cap63.267M
Beta (5Y Monthly)1.18
PE Ratio (TTM)N/A
EPS (TTM)-1.1600
Earnings DateMay 06, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
  • Is Lument Finance Trust, Inc. (LFT) A Good Stock To Buy?
    Insider Monkey

    Is Lument Finance Trust, Inc. (LFT) A Good Stock To Buy?

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 866 13F filings submitted by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of March 31st, 2020. […]

  • Recro Appoints Laura L. Parks, Ph.D. to Board of Directors
    GlobeNewswire

    Recro Appoints Laura L. Parks, Ph.D. to Board of Directors

    Experienced Biopharma Executive with Track Record of Driving Commercial and Operational Success at Global CDMOsEXTON, Pa., June 16, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced the appointment of Laura L. Parks, Ph.D., to the company’s board of directors. Dr. Parks is an e

  • Recro Expands Capabilities for Growing Clinical Trial Services (CTS) Offerings
    GlobeNewswire

    Recro Expands Capabilities for Growing Clinical Trial Services (CTS) Offerings

    Addition of Clinical-Scale Sachet and Blister Packaging Services Further Broadens CTS Offerings; Successful Audit of Facility by EU Qualified Person (QP) Represents Key Step for Attracting and Onboarding European CTS CustomersGAINESVILLE, Ga., June 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug p